InSTRIDE

InSTRIDE focuses on the intersection of substance use and infectious diseases. Current research focuses on treatments for opioid use disorder, specifically among persons with HIV and other infections, and the criminal justice population. Our mission is to improve the lives of persons with substance use disorder through both research and connecting people to community resources.

Dr. Sandra Springer works on the intersection of substance use and infectious disease:

• Appointed Member of the National Academies of Sciences Engineering Medicine (NASEM) Organizing Committee for Opportunities to Improve Opioid Use Disorder and Infectious Disease Services
• Member of the National Academies of Sciences Engineering Medicine (NASEM) Organizing Committee and author of Integrating Responses to the Opioid Use Disorder and Infectious Disease Epidemics:A Report From the National Academies of Sciences, Engineering, and Medicine
• Co Author of American Society of Addiction Medicine (ASAM) Updated National Practice Guideline for Treating Opioid Use Disorder
• Author of Providers Clinical Support System (PCSS) Guidelines: Monitoring of Liver Function Tests in Patients Receiving Naltrexone or Extended-Release Naltrexone. Presenter for Advances in Non-Agonist Therapies SAMHSA (Page 16 of document)
• Co-writer for the Policy on Hepatitis C Diagnosis and Treatment Among Persons who use Drugs
• Clinical Care Options: Incorporating Opioid Use Disorder Screening and Treatment into HIV and HCV Management
• HIV/HCV Roundtable Video
• The Impact of the Opioid Epidemic on New Infectious Disease Epidemics: A Call to Action!

Follow Dr. Springer on Twitter: @SandySpringerMD